[{"bbox": [90, 99, 368, 132], "category": "Page-header", "text": "Q-Line Biotech Limited"}, {"bbox": [140, 170, 1559, 234], "category": "List-item", "text": "Central Depositary Services Limited (CDSL) dated March 05, 2025 and National Securities Depository Limited dated December 31, 2024 for establishing connectivity."}, {"bbox": [90, 265, 769, 298], "category": "List-item", "text": "2. Our Company has a website i.e. www.qlinebiotech.com."}, {"bbox": [90, 329, 1559, 426], "category": "List-item", "text": "3. Except as disclosed in the section titled \"Our Promoters and Promoter Group\" beginning on page 172, there has been no change in the promoters of the Company in the preceding one year from date of filing application to NSE for listing on SME segment."}, {"bbox": [90, 456, 1559, 522], "category": "List-item", "text": "4. All the Equity Shares are fully paid-up and there are no partly paid-up Equity Shares as on the date of filing of this Draft Red Herring Prospectus."}, {"bbox": [90, 552, 1559, 618], "category": "List-item", "text": "5. There has been no change in the promoter(s) having significant change in control over the affairs of the Company in the one year preceding the date of filing application to Emerge Platform of NSE."}, {"bbox": [90, 648, 1559, 714], "category": "Text", "text": "We confirm that we comply with all the below requirements / conditions so as to be eligible to be listed on the SME Platform of NSE (NSE Emerge): -"}, {"bbox": [90, 744, 1559, 1093], "category": "List-item", "text": "1. Our Company was originally incorporated as \"POCT Services Private Limited\" with effect from November 10, 2010 as a Private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated November 10, 2010 issued by the Assistant Registrar of Companies, Uttar Pradesh and Uttarakhand bearing CIN U74120UP2010PTC042528. Subsequently, pursuant to a special resolution passed by our shareholders in the Extra-Ordinary General Meeting held on June 12, 2021, the name of our Company was changed to \"Q-Line Biotech Private Limited and a fresh certificate of incorporation pursuant to change of name dated July 23, 2021 was issued to our Company by the Registrar of Companies, Kanpur. Further, pursuant to a special resolution passed by our Shareholders in the Extra-Ordinary General Meeting held on February 19, 2025, our Company was converted from a private limited company to public limited company and consequently the name of our Company was changed to \"Q-Line Biotech Limited\", and a fresh certificate of incorporation dated March 08, 2025 was issued to our Company by the Registrar of Companies, Central Processing Centre. The CIN of the Company is U74120UP2010PLC042528."}, {"bbox": [90, 1126, 1559, 1192], "category": "List-item", "text": "2. As on the date of this Draft Red Herring Prospectus, the Company has a Paid-up Capital of Rs. 1,627.50 Lakhs and the Post Issue Capital will be of Rs. 2,332.82 Lakhs which is less than Rs. 2,500 lakhs."}, {"bbox": [90, 1223, 903, 1256], "category": "List-item", "text": "3. The Company confirms that it has track record of more than 3 years."}, {"bbox": [90, 1287, 1559, 1383], "category": "List-item", "text": "4. The company/entity has minimum operating profit (earnings before interest, depreciation and tax) from operations for at least any 2 out of 3 financial years preceding the application and its net-worth should be positive as on March 31, 2025, March 31, 2024, and 2023."}, {"bbox": [1404, 1385, 1559, 1414], "category": "Text", "text": "(In Rs. Lacs)"}, {"bbox": [90, 1414, 1559, 1580], "category": "Table", "text": "<table><thead><tr><th rowspan=\"2\">Particulars</th><th>March 31, 2025</th><th>March 31, 2024</th><th>March 31, 2023</th></tr><tr><th colspan=\"3\">Consolidated</th></tr></thead><tbody><tr><td>Net Worth</td><td>18994.53</td><td>16181.44</td><td>12736.52</td></tr><tr><td>Operating profit (earnings before interest, depreciation, and tax)</td><td>7132.12</td><td>3762.50</td><td>3297.72</td></tr></tbody></table>"}, {"bbox": [90, 1613, 1559, 1678], "category": "List-item", "text": "5. The company/entity has positive Free cash flow to Equity (FCFE) for at least 2 out of 3 financial years as per audited financials preceding the application."}, {"bbox": [1414, 1679, 1559, 1708], "category": "Text", "text": "(â‚¹ in Lakhs)"}, {"bbox": [90, 1708, 1559, 2009], "category": "Table", "text": "<table><thead><tr><th rowspan=\"3\">Particulars</th><th colspan=\"3\">For the financial year ended on</th></tr><tr><th>March 31, 2025</th><th>March 31, 2024</th><th>March 31, 2023</th></tr><tr><th colspan=\"3\">Consolidated</th></tr></thead><tbody><tr><td>Net Cash flow from Operations</td><td>(128.45)</td><td>(2417.94)</td><td>2496.86</td></tr><tr><td>Less- Purchase of Fixed Assets (net of sale proceeds of Fixed Assets)</td><td>4953.22</td><td>4693.82</td><td>3135.47</td></tr><tr><td>Add- Net Total Borrowings (net of repayment)</td><td>6,803.98</td><td>2,326.15</td><td>3,019.93</td></tr><tr><td>Less- Interest expense (1-T)</td><td>732.76</td><td>417.10</td><td>220.33</td></tr><tr><td>Free cash flow to Equity (FCFE)</td><td>989.55</td><td>-5,202.71</td><td>2,160.99</td></tr></tbody></table>"}, {"bbox": [90, 2042, 1559, 2107], "category": "List-item", "text": "6. Our Company confirms that there is no material regulatory or disciplinary action by a stock exchange or regulatory authority in the past one year in respect of promoters, Group Companies, companies promoted by the promoters of the Company;"}, {"bbox": [90, 2138, 1559, 2170], "category": "List-item", "text": "7. Our Company has not been referred to the Board for Industrial and Financial Reconstruction (BIFR) or no proceedings have"}, {"bbox": [802, 2172, 848, 2201], "category": "Page-footer", "text": "322"}]